Sterile Vials Market (By Product: Sterile Empty Vial, Sterile Liquid Filled Vial, and Individual Sterilized Components [ISCs]; By Volume: <2ml, 2 ml to 5 ml, 5 ml to 10 ml, 10 ml to 20 ml, and >20ml; By Material: Glass and Plastic; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

The global sterile vials market value reached at US$ 4.5 Bn in 2020 and predicted to surpass over 12 billion by 2030, expanding at a noteworthy CAGR of 8.1% from 2021 to 2030. Growth of biologics and combination drug/device products across the globe, increase in global geriatric population, and rise in awareness among consumers about infections are anticipated to propel the global sterile vials market.

Key Driver

Drug and pharmaceutical manufacturers need to maintain the required quality of sensitive medicines while storing and supplying. Drugs and medicines come in contact with storage containers made of aluminum and other vessels that impart some amount of flavor into the drugs, which degrades the quality. However, glass vials are non-reactive with the drug stored in them. Moreover, these glass vials are dust-resistant and easy to clean. Furthermore, features such as longer shelf life and contamination-free storage increase the popularity of glass vials.

Rise in inclination of various end users, such as biopharmaceutical companies, CMOs, and clinical labs, toward glass vials boosts the growth of the global sterile vials market. Moreover, glass vials are easily recyclable, and glass is considered eco-friendly material, which propels its popularity. This shift in focus of end users from conventional containers and vials to glass vials propels the global sterile vials market.

High Adoption of Glass Vials Compared to Alternative Containers to Drive Market

Drug and pharmaceutical manufacturers need to maintain the required quality of sensitive medicines, while storing and supplying. Drugs and medicines come in contact with drug storage containers made of aluminum and other vessels that impart some amount of flavor into the drugs, which degrades the quality of the drugs. However, glass vials are non-reactive with the drug stored in them. Moreover, these glass vials are dust-resistant and easy to clean. Furthermore, features such as longer shelf life and contamination-free storage increase the popularity of glass vials.

Rise in inclination of various end users, such as biopharmaceutical companies, CMOs, and clinical labs toward glass vials drives the global sterile vials market. Moreover, glass vials are easily recyclable and glass is considered eco-friendly material, which propels its popularity. This shift in focus of end users from conventional containers and vials to glass vials augments the global sterile vials market.

Hybrid Packaging Solutions Help Meet Global Demand for COVID-19 Sterile Vials

While pharmaceutical companies are highly focused on coronavirus vaccine development, they are also considering primary packaging alternatives to fill, store, and distribute billions of vaccine doses worldwide. However, pharma companies are facing a global shortage of borosilicate glass due to unexpected and unprecedented demand for sterile vials. On the other hand, ordinary plastics increase risk of compromising drug efficacy and stability. Hence, companies in the sterile vials market are increasing their research in hybrid packaging solutions involving SiO2 (Silica) Materials Science that combines glass and plastic without their respective drawbacks.

Multi-layer Extrusion Blow Molding Technology in Vials Offers Robust Moisture Barrier

Innovative pharmaceutical packaging solutions for oral liquids pertaining to human health and sterile injectables for animal health are translating into revenue opportunities for companies in the sterile vials market. Honeywell International Inc. - the U.S. publicly traded multinational conglomerate, has announced its Aclar Edge pharmaceutical packaging solution made using their proprietary multi-layer extrusion blow molding technology. Manufacturers are taking cues from such innovations to adopt technologies that improve user safety during handling and administration.

Novel sterile vials and bottles help to preserve the shelf life of oral liquids and sterile injectables for a large variety of challenging applications. Manufacturers in the sterile vials market are bolstering their output capacities in containers that perform robust moisture barrier and enhanced oxygen barrier as compared to polymeric containers.

Report Highlights

In terms of product, the global sterile vials market has been classified into sterile empty vial, sterile liquid filled vial, and individual sterilized components (ISCs). The sterile empty vial segment held major market share in 2020 and the trend is projected to continue during the forecast period. The segment is anticipated to register the highest market attractiveness during the forecast period.

Based on volume, the global sterile vials market has been categorized into <2ml, 2ml to 5ml, 5ml to 10ml, 10ml to 20ml, and >20ml. The 2ml to 5ml segment accounted for a major share of 28.84% of the global sterile vials market in 2020. The 2ml to 5ml segment is anticipated to create incremental opportunity of US$ 2,276.6 Mn during the forecast period. The segment is expected to capture 30.12% market share by 2030. The segment is likely to expand at the highest CAGR of 8.7% from 2021 to 2030. Rapid expansion of the pharmaceutical industry is projected to create significant opportunities for manufacturers of 5 ml to 10 ml sterile vials.

In terms of material, the global sterile vials market has been bifurcated into glass and plastic. The glass segment held 79.79% share of the global sterile vials market in 2020. The segment is expected to gain 114 basis points to reach 80.93% by 2030. The segment is likely to reach US$ 9,745.2 Mn by 2030, expanding at a CAGR of 8.5% during the forecast period. Glass vials are specifically designed to withstand extreme conditions encountered during the lyophilization process, with a flat bottom to optimize heat transfer. A 30% reduction in vial weight, uniform wall thickness for better mechanical resistance, and standard 20mm ISO neck compatible with all closures and reconstitution systems on the market augment the segment.

North America is projected to be a highly attractive market for sterile vials during the forecast period. The region is anticipated to account for the largest share of the global market by 2030. Easy availability of raw materials for medical packaging in the region is expected to drive the market in North America. Increase in capital investment by leading manufacturers in the pharmaceutical packaging industry augments the sterile vials market in the region. For instance, in September 2017, Schott AG expanded manufacturing in the U.S. with investment in new generation of pharmaceutical sterile vials. International technology group Schott increased investment in the latest generation of pharmaceutical vials, mapping a future of stronger packaging options for pharmaceutical companies.

Europe is likely to be the second most attractive market for sterile vials during the forecast period. The market in the region is anticipated to expand at a high CAGR from 2021 to 2030. Increase in development of biologics, antibody-drug conjugates, and monoclonal antibodies have driven the demand for sterile vials in the region. This fuels the growth of the sterile vials market in Europe during the forecast period.

Key Players

The report provides profiles of leading players operating in the global sterile vials market. These include Adelphi Healthcare Packaging, APG Europe, Bormioli Pharma S.p.a., Corning Incorporated, Dalton Pharma Services, DWK Life Sciences GmbH, Gerresheimer AG, Nipro Corporation, O.Berk Company, Pacific Vial, Piramal Glass (Piramal Enterprises Ltd.), Schott AG, SDG Pharma, Shandong Pharmaceutical Glass Co. Ltd., SiO2 Materials Science, Stevanato Group, Thermo Fisher Scientific, Inc., and West Pharmaceutical Services, Inc.

Market Segmentation

  • By Product
    • Sterile Empty Vial
      • Sterile Evacuated Vial
      • Sterile Nitrogen Filled Vial
      • Sterile Air Filled Vial
    • Sterile Liquid Filled Vial
      • Sterile Saline Filled Vial
      • Sterile Media Filled Vial
      • Sterile Water Filled Vial
    • Individual Sterilized Components (ISCs)
  • By Volume
    • <2 ml
    • 2 ml to 5 ml
    • 5 ml to 10 ml
    • 10 ml to 20 ml
    • >20 ml
  • By Material
    • Glass
    • Plastic
  • By End User
    • Clinical Labs
    • Compounding Labs
    • Biopharmaceutical Companies
    • CMOs
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific          
      • China
      • India
      • Japan
      • South Korea
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

The Sterile vials market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Sterile vials market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Sterile vials market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sterile vials market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Sterile vials market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Sterile vials capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Sterile vials by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Sterile vials market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Sterile vials market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Sterile vials market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Sterile vials industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Sterile vials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Sterile vials market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Sterile vials market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Sterile vials market. These factors have benefited the growth of the global market for Sterile vials. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Sterile vials. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the sterile vials market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the sterile vials market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Sterile vials market.

Market Segments: This part of the report discusses about product, application and other segments of the sterile vials market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses about the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

In this study, the years considered to estimate the market size of Sterile vials are as follows:

  • History Year: 2017-2020
  • Base Year: 2020
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  •  
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

 

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sterile Vials Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

        4.3.4. Trends

    4.4. Global Sterile Vials Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections 

5. Key Insights

    5.1. Recent Development (industry updates, merger & acquisitions)

    5.2. Key Vendor and Distributor Analysis

    5.3. Sterile Vials Pricing Analysis

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Sterile Vials Market Analysis and Forecasts, by Product 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value and Volume Forecast by Product, 2017–2031

        6.3.1. Sterile Empty Vial

            6.3.1.1. Sterile Evacuated Vial

            6.3.1.2. Sterile Nitrogen Filled Vial

            6.3.1.3. Sterile Air Filled Vial

        6.3.2. Sterile Liquid Filled Vial

            6.3.2.1. Sterile Saline Filled Vial

            6.3.2.2. Sterile Media Filled Vial

            6.3.2.3. Sterile Water Filled Vial

        6.3.3. Individual Sterilized Components (ISCs)

    6.4. Market Attractiveness Analysis, by Product 

7. Global Sterile Vials Market Analysis and Forecast, by Volume 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value and Volume Forecast, by Volume, 2017–2031

        7.3.1. <2ml

        7.3.2. 2 ml to 5ml

        7.3.3. 5 ml to 10 ml

        7.3.4. 10 ml to 20 ml

        7.3.5. >20ml

    7.4. Market Attractiveness Analysis, by Volume 

8. Global Sterile Vials Market Analysis and Forecast, by Material 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value & Volume Forecast, by Material, 2017–2031

        8.3.1. Glass

        8.3.2. Plastic

    8.4. Market Attractiveness Analysis, by Material 

9. Global Sterile Vials Market Analysis and Forecast, by End-user 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value and Volume Forecast, by End-user, 2017–2031

        9.3.1. Clinical Labs

        9.3.2. Compounding Labs

        9.3.3. Biopharmaceutical Companies

        9.3.4. CMOs

        9.3.5. Others

    9.4. Market Attractiveness Analysis, by End-user 

10. Global Sterile Vials Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value and Volume Forecast, by Region

        10.2.1. North America 

        10.2.2. Europe 

        10.2.3. Asia Pacific 

        10.2.4. Latin America 

        10.2.5. Middle East & Africa 

    10.3. Market Attractiveness Analysis, by Country/Region

11. North America Sterile Vials Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value and Volume Forecast, by Product, 2017–2031

        11.2.1. Sterile Empty Vial

            11.2.1.1. Sterile Evacuated Vial

            11.2.1.2. Sterile Nitrogen Filled Vial

            11.2.1.3. Sterile Air Filled Vial

        11.2.2. Sterile Liquid Filled Vial

            11.2.2.1. Sterile Saline Filled Vial

            11.2.2.2. Sterile Media Filled Vial

            11.2.2.3. Sterile Water Filled Vial

        11.2.3. Individual Sterilized Components (ISCs)

    11.3. Market Value and Volume Forecast, by Volume, 2017–2031

        11.3.1. <2ml

        11.3.2. 2 ml to 5ml

        11.3.3. 5 ml to 10 ml

        11.3.4. 10 ml to 20 ml

        11.3.5. >20ml

    11.4. Market Value & Volume Forecast, by Material, 2017–2031

        11.4.1. Glass

        11.4.2. Plastic

    11.5. Market Value and Volume Forecast, by End-user, 2017–2031

        11.5.1. Clinical Labs

        11.5.2. Compounding Labs

        11.5.3. Biopharmaceutical Companies

        11.5.4. CMOs

        11.5.5. Others

    11.6. Market Value and Volume Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis 

        11.7.1. By Product 

        11.7.2. By Volume 

        11.7.3. By Material 

        11.7.4. By End-user 

        11.7.5. By Country

12. Europe Sterile Vials Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value and Volume Forecast, by Product, 2017–2031

        12.2.1. Sterile Empty Vial

            12.2.1.1. Sterile Evacuated Vial

            12.2.1.2. Sterile Nitrogen Filled Vial

            12.2.1.3. Sterile Air Filled Vial

        12.2.2. Sterile Liquid Filled Vial

            12.2.2.1. Sterile Saline Filled Vial

            12.2.2.2. Sterile Media Filled Vial

            12.2.2.3. Sterile Water Filled Vial

        12.2.3. Individual Sterilized Components (ISCs)

    12.3. Market Value and Volume Forecast, by Volume, 2017–2031

        12.3.1. <2ml

        12.3.2. 2 ml to 5ml

        12.3.3. 5 ml to 10 ml

        12.3.4. 10 ml to 20 ml

        12.3.5. >20ml

    12.4. Market Value & Volume Forecast, by Material, 2017–2031

        12.4.1. Glass

        12.4.2. Plastic

    12.5. Market Value and Volume Forecast, by End-user, 2017–2031

        12.5.1. Clinical Labs

        12.5.2. Compounding Labs

        12.5.3. Biopharmaceutical Companies

        12.5.4. CMOs

        12.5.5. Others

    12.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis 

        12.7.1. By Product 

        12.7.2. By Volume 

        12.7.3. By Material 

        12.7.4. By End-user 

        12.7.5. By Country/Sub-region

13. Asia Pacific Sterile Vials Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value and Volume Forecast, by Product, 2017–2031

        13.2.1. Sterile Empty Vial

            13.2.1.1. Sterile Evacuated Vial

            13.2.1.2. Sterile Nitrogen Filled Vial

            13.2.1.3. Sterile Air Filled Vial

        13.2.2. Sterile Liquid Filled Vial

            13.2.2.1. Sterile Saline Filled Vial

            13.2.2.2. Sterile Media Filled Vial

            13.2.2.3. Sterile Water Filled Vial

        13.2.3. Individual Sterilized Components (ISCs)

    13.3. Market Value and Volume Forecast, by Volume, 2017–2031

        13.3.1. <2ml

        13.3.2. 2 ml to 5ml

        13.3.3. 5 ml to 10 ml

        13.3.4. 10 ml to 20 ml

        13.3.5. >20ml

    13.4. Market Value & Volume Forecast, by Material, 2017–2031

        13.4.1. Glass

        13.4.2. Plastic

    13.5. Market Value and Volume Forecast, by End-user, 2017–2031

        13.5.1. Clinical Labs

        13.5.2. Compounding Labs

        13.5.3. Biopharmaceutical Companies

        13.5.4. CMOs

        13.5.5. Others

    13.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis 

        13.7.1. By Product 

        13.7.2. By Volume 

        13.7.3. By Material 

        13.7.4. By End-user 

        13.7.5. By Country/Sub-region

14. Latin America Sterile Vials Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value and Volume Forecast, by Product, 2017–2031

        14.2.1. Sterile Empty Vial

            14.2.1.1. Sterile Evacuated Vial

            14.2.1.2. Sterile Nitrogen Filled Vial

            14.2.1.3. Sterile Air Filled Vial

        14.2.2. Sterile Liquid Filled Vial

            14.2.2.1. Sterile Saline Filled Vial

            14.2.2.2. Sterile Media Filled Vial

            14.2.2.3. Sterile Water Filled Vial

        14.2.3. Individual Sterilized Components (ISCs)

    14.3. Market Value and Volume Forecast, by Volume, 2017–2031

        14.3.1. <2ml

        14.3.2. 2 ml to 5ml

        14.3.3. 5 ml to 10 ml

        14.3.4. 10 ml to 20 ml

        14.3.5. >20ml

    14.4. Market Value & Volume Forecast, by Material, 2017–2031

        14.4.1. Glass

        14.4.2. Plastic

    14.5. Market Value and Volume Forecast, by End-user, 2017–2031

        14.5.1. Clinical Labs

        14.5.2. Compounding Labs

        14.5.3. Biopharmaceutical Companies

        14.5.4. CMOs

        14.5.5. Others

    14.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis 

        14.7.1. By Product 

        14.7.2. By Volume 

        14.7.3. By Material 

        14.7.4. By End-user 

        14.7.5. By Country/Sub-region

15. Middle East & Africa Sterile Vials Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value and Volume Forecast, by Product, 2017–2031

        15.2.1. Sterile Empty Vial

            15.2.1.1. Sterile Evacuated Vial

            15.2.1.2. Sterile Nitrogen Filled Vial

            15.2.1.3. Sterile Air Filled Vial

        15.2.2. Sterile Liquid Filled Vial

            15.2.2.1. Sterile Saline Filled Vial

            15.2.2.2. Sterile Media Filled Vial

            15.2.2.3. Sterile Water Filled Vial

        15.2.3. Individual Sterilized Components (ISCs)

    15.3. Market Value and Volume Forecast, by Volume, 2017–2031

        15.3.1. <2ml

        15.3.2. 2 ml to 5ml

        15.3.3. 5 ml to 10 ml

        15.3.4. 10 ml to 20ml

        15.3.5. >20ml

    15.4. Market Value & Volume Forecast, by Material, 2017–2031

        15.4.1. Glass

        15.4.2. Plastic

    15.5. Market Value and Volume Forecast, by End-user, 2017–2031

        15.5.1. Clinical Labs

        15.5.2. Compounding Labs

        15.5.3. Biopharmaceutical Companies

        15.5.4. CMOs

        15.5.5. Others

    15.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis 

        15.7.1. By Product 

        15.7.2. By Volume 

        15.7.3. By Material 

        15.7.4. By End-user 

        15.7.5. By Country/Sub-region

16. Competitive Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Company Profiles

        16.2.1. Adelphi Healthcare Packaging (The Adelphi Group Of Companies)

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Financial Overview

            16.2.1.3. Product Portfolio

            16.2.1.4. Strategic Overview

            16.2.1.5. SWOT Analysis

        16.2.2. APG Europe

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Financial Overview

            16.2.2.3. Product Portfolio

            16.2.2.4. Strategic Overview

            16.2.2.5. SWOT Analysis

        16.2.3. Bormioli Pharma S.p.a.

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Financial Overview

            16.2.3.3. Product Portfolio

            16.2.3.4. Strategic Overview

            16.2.3.5. SWOT Analysis

        16.2.4. Corning Incorporated

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Financial Overview

            16.2.4.3. Product Portfolio

            16.2.4.4. Strategic Overview

            16.2.4.5. SWOT Analysis

        16.2.5. Dalton Pharma Services

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Financial Overview

            16.2.5.3. Product Portfolio

            16.2.5.4. Strategic Overview

            16.2.5.5. SWOT Analysis

        16.2.6. DWK Life Sciences GmbH

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Financial Overview

            16.2.6.3. Product Portfolio

            16.2.6.4. Strategic Overview

            16.2.6.5. SWOT Analysis

        16.2.7. Gerresheimer AG

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Financial Overview

            16.2.7.3. Product Portfolio

            16.2.7.4. Strategic Overview

            16.2.7.5. SWOT Analysis

        16.2.8. Nipro Corporation

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Financial Overview

            16.2.8.3. Product Portfolio

            16.2.8.4. Strategic Overview

            16.2.8.5. SWOT Analysis

        16.2.9. O.Berk Company

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Financial Overview

            16.2.9.3. Product Portfolio

            16.2.9.4. Strategic Overview

            16.2.9.5. SWOT Analysis 

        16.2.10. Pacific Vial

            16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.10.2. Financial Overview

            16.2.10.3. Product Portfolio

            16.2.10.4. Strategic Overview

            16.2.10.5. SWOT Analysis

        16.2.11. Piramal Glass (Piramal Enterprises Ltd.)

            16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.11.2. Financial Overview

            16.2.11.3. Product Portfolio

            16.2.11.4. Strategic Overview

            16.2.11.5. SWOT Analysis

        16.2.12. Schott AG

            16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.12.2. Financial Overview

            16.2.12.3. Product Portfolio

            16.2.12.4. Strategic Overview

            16.2.12.5. SWOT Analysis

        16.2.13. SDG Pharma

            16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.13.2. Financial Overview

            16.2.13.3. Product Portfolio

            16.2.13.4. Strategic Overview

            16.2.13.5. SWOT Analysis

        16.2.14. Shandong Pharmaceutical Glass Co. Ltd.

            16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.14.2. Financial Overview

            16.2.14.3. Product Portfolio

            16.2.14.4. Strategic Overview

            16.2.14.5. SWOT Analysis

        16.2.15. SiO2 Materials Science

            16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.15.2. Financial Overview

            16.2.15.3. Product Portfolio

            16.2.15.4. Strategic Overview

            16.2.15.5. SWOT Analysis

        16.2.16. Stevanato Group

            16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.16.2. Financial Overview

            16.2.16.3. Product Portfolio

            16.2.16.4. Strategic Overview

            16.2.16.5. SWOT Analysis

        16.2.17. Thermo Fisher Scientific, Inc.

            16.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.17.2. Financial Overview

            16.2.17.3. Product Portfolio

            16.2.17.4. Strategic Overview

            16.2.17.5. SWOT Analysis

        16.2.18. West Pharmaceutical Services, Inc.

            16.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.18.2. Financial Overview

            16.2.18.3. Product Portfolio

            16.2.18.4. Strategic Overview

            16.2.18.5. SWOT Analysis

 

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers